Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Cash from Financing Activities (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Cash from Financing Activities for 9 consecutive years, with $18.0 million as the latest value for Q1 2026.

  • For Q1 2026, Cash from Financing Activities fell 63.57% year-over-year to $18.0 million; the TTM value through Mar 2026 reached -$194.5 million, up 50.74%, while the annual FY2025 figure was -$163.2 million, 47.57% up from the prior year.
  • Cash from Financing Activities hit $18.0 million in Q1 2026 for Select Medical Holdings, up from -$31.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $133.0 million in Q1 2024 and bottomed at -$205.5 million in Q2 2024.
  • Average Cash from Financing Activities over 5 years is -$48.2 million, with a median of -$46.5 million recorded in 2025.
  • Year-over-year, Cash from Financing Activities plummeted 400.5% in 2023 and then soared 3788.86% in 2024.
  • Select Medical Holdings' Cash from Financing Activities stood at $34.4 million in 2022, then tumbled by 400.5% to -$103.3 million in 2023, then tumbled by 77.18% to -$183.0 million in 2024, then surged by 83.08% to -$31.0 million in 2025, then skyrocketed by 157.99% to $18.0 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $18.0 million, -$31.0 million, and -$135.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.